Cytokines, such as SDF-1, support proliferation and migration of breast cancer cells expressing CXCR4 receptor [11], as well as high serum levels of Interleukin-6 and Interleukin-8 are associated with poor outcome in breast cancer patients [12, 13]. This evidence concerns the gene IL6 and breast carcinoma.